Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials (Q38413170)
Jump to navigation
Jump to search
scientific article published on July 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials |
scientific article published on July 2015 |
Statements
1 reference
Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials (English)
1 reference
Makoto Araie
1 reference
Hidenobu Tanihara
1 reference
Toshihiro Inoue
1 reference
Tetsuya Yamamoto
1 reference
Yasuaki Kuwayama
1 reference
Haruki Abe
1 reference
Hideki Suganami
1 reference
K-115 Clinical Study Group
1 reference
1 July 2015
1 reference
1 reference
133
1 reference
7
1 reference
755-761
1 reference
Identifiers
1 reference
1 reference